The focus is specifically on neonatal intensive care units, the company says. By integrating with the Epic electronic health record, GeneDx aims to connect directly with health systems, helping ...

GeneDx Holdings Corp. (NASDAQ:WGS) is one of the best digital health stocks to buy now. On October 29, 2025, Guggenheim lifted GeneDx (NASDAQ:WGS) to a $170 price target (Buy) after the company's blow ...

It's rarely a happy occasion when a company announces a reverse stock split. That's because this typically means that it's having trouble compiling with minimum share price listing requirements on an ...

In the latest quarter, 5 analysts provided ratings for GeneDx Hldgs (NASDAQ:WGS), showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview of their recent ...

Fintel reports that on December 15, 2025, Wells Fargo maintained coverage of GeneDx Holdings (NasdaqGS:WGS) with a ...

STAMFORD, Conn., Sept. 11, 2023 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS) a leader in delivering improved health outcomes through genomic and clinical insights, today announced the expansion and ...

GeneDx Holdings Corp. (NASDAQ:WGS) shares are soaring after the company reported its first-quarter financial results after the bell Monday. Here's a look at the highlights. The Details: GeneDx ...

Several pundits raised their price targets on the specialty healthcare company. This was hardly a surprise, as they came on the heels of an excellent earnings report. GeneDx's second-quarter earnings ...

GeneDx (NASDAQ:WSG) announced plans on Wednesday to acquire Fabric Genomics, a pioneer in AI-powered genomic interpretation, to create a leading platform for rare disease diagnostics and newborn ...

Powered by GeneDx Infinity™ with unparalleled scale and diversity, GeneDx fuels breakthrough scientific research and delivers the most precise rare disease diagnosis for patients and families ...